Research Article| Volume 46, ISSUE 4, P296-299, 1993

Effects of ketorolac tromethamine (ToradolR) on a functional model of microvascular thrombosis

      This paper is only available as a PDF. To read, Please Download here.


      Ketorolac tromethamine (ToradolR), a potent nonsteroidal anti-inflammatory drug used for postoperative pain, also strongly inhibits platelet agregation. The anti-thrombotic effects of intramuscular ketorolac were assessed with a described rat model of microarterial thrombosis. After a single dose of ketorolac mean bleeding times were significantly prolonged (p < 0.01) and platelet aggregation was markedly reduced. Patency rates at 20 min were significantly higher in ketorolac groups compared to controls (p < 0.005). However, all vessels were thrombosed at 24h. Scanning electron microscopy demonstrated decreased platelet aggregation and decreased thrombus formation in ketorolac treated animals at 20 min. The prolonged bleeding time and reduction in platelet aggregation add support to concerns of bleeding complications reported in patients treated with ketorolac perioperatively. Thus, ketorolac should probably not be used for pain relief in patients in whom postoperative haematoma formation is a particular concern. In addition, in this model, ketorolac as a single agent was ineffective for long-term prevention of microarterial thrombosis.


        • Weiland AJ
        • Villarreal-Rios A
        • Klein HE
        • Kutz J
        • Atasoy E
        • Lister G
        Replantation of digits and hands: analyses of surgical technique and functional results in 71 patients with 86 replantations.
        J Hand Surg. 1977; 2: 1-9
        • Shaw WW
        • Converse JM
        A survey of 2680 free flaps: survival, donor site and applications among experienced microvascular surgeons.
        in: Proceedings of the Fiftieth Annual Convention of the American Society of Plastic and Reconstructive Surgery. 7th edition. Plast Surg Forum. 4. 1987: 93-98
        • Davies DM
        A world survey of anticoagulation practice in clinical microvascular surgery.
        Br J Plast Surg. 1982; 35: 96-99
        • Rosenbaum TJ
        • Sundt Jr, TM
        Thrombus formation and endothelial alterations in microarterial anastomoses.
        J Neurosurgery. 1977; 47: 430-441
        • Cooley BC
        • Ruas EJ
        • Shaw-Wilgis EF
        Scanning electron microscopy of crush/avulsion arterial trauma: effect of heparin and aspirin administration.
        Microsurgery. 1987; 8: 11-16
        • Greenberg BM
        • Masem M
        • May Jr, JW
        Therapeutic value of intravenous heparin in microvascular surgery: an experimental vascular thrombosis study.
        Plast Reconst Surg. 1988; 82: 463-470
        • Khouri RK
        • Cooley BC
        • Kenna DM
        • Edstrom LE
        Thrombosis of microvascular anastomoses in traumatized vessels: fibrin versus platelets.
        Plast Reconst Surg. 1990; 86: 110-117
        • Davidson SF
        • Brantley SK
        • Talbot PJ
        • Das SK
        A functional model of microvascular thrombosis.
        Plant Reconst Surg. 1990; 86: 579-581
        • Davidson SF
        • Brantley SK
        • Das SK
        Comparison of single dose antithrombotic agents in the prevention of microvascular thrombosis.
        J Hand Surg. 1991; 16: 585-589
        • Cox GW
        • Runnels S
        • Hsu HS-H
        • Das SK
        A comparison of heparinised saline irrigation solutions in a model of microvascular thrombosis.
        Br J Plast Surg. 1992; 45: 345-348
        • Goodman LS
        • Gillman AG
        The Pharmacologic Basis of Therapeutics.
        in: 7th edition. MacMillan, New York1985: 1354
        • Goodman LS
        • Gillman AG
        The Pharmacologic Basis of Therapeutics.
        in: 7th edition. MacMillan, New York1985: 1366
        • Conrad KA
        • Fagan TC
        • Mackie MJ
        • Mayshar PV
        Effects of ketorolac tromethamine on hemostasis in volunteers.
        Clin Pharmacol Ther. 1988; 43: 542-546
        • Mroszcak EJ
        • Frank WL
        • Combs D
        • et al.
        Ketorolac tromethamine absorption, distribution, metabolism, excretion and pharmacokinetics in animals and humans.
        Drug Metab Dispos. 1987; 15: 618-626
        • Dejana E
        • Callioni A
        • Quintana A
        • deGaetano G
        Bleeding time in laboratory animals. II — A comparison of different assay conditions in rats.
        Thromb Res. 1979; 15: 191-197
        • Moore M
        UMMC platelet aggregation protocol.
        University of Mississippi Medical Center Department of Pathology, Jackson, Ms1990
        • Greer IA
        Effects of ketorolac tromethamine on hemostasis.
        Pharmacotherapy. 1990; 10 (6 part 2): 715-765
      1. Syntex Product Monograph of Toradol (Ketorolac tromethamine). Syntex Laboratories, Inc, Palo Alto, CA1990
        • Garsha IS
        • Bostwick J
        Postoperative hematomas associated with Toradol.
        Plast Reconst Surg. 1991; 88: 919-920
        • Concannon MJ
        • Welsh CF
        • Puckett CL
        Inhibition of perioperative platelet aggregation using Toradol.
        South Med J. 1991; 84: 2S-72